Snowball logo
logo
IKT_logo

Inhibikase Therapeutics Inc

IKT NASDAQ
$2.00+$0.01  (0.5%)

Frequently asked questions

What sector does Inhibikase Therapeutics Inc (IKT) operate in?

Inhibikase Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Inhibikase Therapeutics Inc (IKT) current stock price?

As of the latest data, Inhibikase Therapeutics Inc stock price is $2.00, with a previous close of $1.99. Inhibikase Therapeutics Inc gained $0.01 in the last trading session, representing a 0.5% increase.

What is Inhibikase Therapeutics Inc (IKT) current market capitalization?

Inhibikase Therapeutics Inc market cap is approximately 149.03 million.

What is Inhibikase Therapeutics Inc (IKT) Earnings Per Share (EPS)?

The trailing EPS is -$0.04, and the forward EPS is -$0.73.

What is Inhibikase Therapeutics Inc (IKT) EBITDA?

Inhibikase Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -11.91 million.

Does Inhibikase Therapeutics Inc (IKT) pay dividends?

No. Inhibikase Therapeutics Inc does not pay a dividend.

What is Inhibikase Therapeutics Inc (IKT) beta (volatility) score?

Inhibikase Therapeutics Inc has a beta of 0.890, meaning its volatility is roughly in line with the market.